Skip to main content
Log in

Fulminant hepatic failure in a child as a potential adverse effect of trimethoprim-sulphamethoxazole

  • Gastroenterology/Hepatology
  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Abstract

Trimethoprim-sulphamethoxazole (TMP-SMZ) is considered a safe drug for treatment of infectious bacterial diseases in children. Side-effects are rare and generally take the form of a hypersensitivity reaction to the sulphamethoxazole component of the drug. Hepatic injury usually presents as a transient elevation of liver enzymes, which is of little clinical relevance. Fulminant liver failure due to TMP-SMZ has been reported in only six adults and never in children. We here report a 5-year-old girl who developed fulminant liver failure 3 weeks after her third exposure to TMP-SMZ. After a biphasic clinical course she underwent successful liver transplantation.

Conclusion

Trimethoprim-Sulphamethoxazole may cause fulminant liver failure in children. The disease can run a biphasic clinical course and liver transplantation must be considered as the therapeutic option for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

TMP-SM2 :

trimethoprim-sulphamethoxazole

References

  1. Alberti-Flor JJ, Hernandez ME, Ferrer JP, et al (1989) Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim. Am J Gastroenterol 84: 1577–1579

    PubMed  Google Scholar 

  2. Burdelski M, Oellerich M, Düwel J, et al (1992) Pre- and post-transplant assessment of liver function in pediatric liver transplantation. Eur J Pediatr 151 [Suppl 1]: S39-S43

    PubMed  Google Scholar 

  3. Devictor D, Deplanques L, Debray D, et al (1992) Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology 16: 1156–1162

    PubMed  Google Scholar 

  4. Endres W, Sierek T, Shin YS (1988) Clinical course of hereditary fructose intolerance in 56 patients. Acta Paediatr Jpn 30: 452–456

    PubMed  Google Scholar 

  5. Horak J, Mertl L, Hrabal P (1984) Severe liver injuries due to sulfamethoxazole-trimetoprim and sulfamethoxydiazin. Hepatogastroenterol 31: 199–200

    Google Scholar 

  6. Mazziotta MRM, Ricci E, Bertini E, et al (1992) Fatal infantile liver failure associated with mitochondrial DNA depletion. J Pediatr 121: 896–901

    PubMed  Google Scholar 

  7. Ransohoff DF, Jacobs G (1981) Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim. Gastroenterology 80: 816–819

    PubMed  Google Scholar 

  8. Samson JF, Barth PG, Vries JIP de, Menko FH, Ruitenbeck W, Ooost BA van, Jakobs C (1994) Familial mitochondrial encephalopathy with fetal ultrasonographic ventriculomegaly and intracerebral calcifications. Eur J Pediatr 153: 510–516

    PubMed  Google Scholar 

  9. Sherlock S (1986) The spectrum of hepatotoxicity due to drugs. Lancet II: 440–444

    Google Scholar 

  10. Stricker BHC, Spoelstra P (1989) Drug-induced hepatic injury. In: Dukes MNG, (ed) Drug-induced disorders. Elsevier, Amsterdam, pp 1177–1182

    Google Scholar 

  11. Whitington PF, Balistreri WF (1991) Liver transplantation in pediatrics: Indications, contraindications, and pretransplant management. J Pediatr 118: 169–177

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simma, B., Meister, B., Deutsch, J. et al. Fulminant hepatic failure in a child as a potential adverse effect of trimethoprim-sulphamethoxazole. Eur J Pediatr 154, 530–533 (1995). https://doi.org/10.1007/BF02074828

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02074828

Key words

Navigation